Literature DB >> 791036

The maximal expiratory flow-volume curve: its use in the detection of ventilatory abnormalities in a population study.

R J Knudson, B Burrows, M D Lebowitz.   

Abstract

Flow-volume and spirometric parameters obtained in a randomly selected population were examined with regard to their sensitivity in detecting abnormalities among persons who smoked and/or had respiratory symptoms. Data obtained from subjects who were totally free of cardiorespiratory symptoms and who had never smoked cigarettes were used to develop "normal" prediction equations. Using as normal limits the per cent of predicted value above which 95% of these "normal" subjects fell, maximal expiratory flow at 75% of the expired vital capacity (Vmax75) detected the greatest proportion of abnormalities in the remainder of the population. When examined according to age, however, Vmax75 was most sensitive in older subjects, whereas 1-sec forced expiratory volume was superior in younger subjects. There was a slight tendency for Vmax75 to be affected in subjects with reactive airway syndromes and for the 1-sec forced expiratory volume to be affected in heavy smokers or subjects with chronic productive cough. If one parameter was markedly abnormal, the entire flow-volume curve was likely to be affected, but concordance of the parameters examined was not complete. For the latter reason, considerable caution must be exercised in attempting to use multiple parameters in defining abnormality, unless one applies more stringent criteria for abnormality.

Entities:  

Mesh:

Year:  1976        PMID: 791036     DOI: 10.1164/arrd.1976.114.5.871

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  14 in total

1.  Changes in maximum expiratory flow-volume curve configuration after treatment with inhaled corticosteroids.

Authors:  J Kraan; T W van der Mark; G H Koëter
Journal:  Thorax       Date:  1989-12       Impact factor: 9.139

2.  Peripheral airway function in healthy young cigarette smokers.

Authors:  G N Harrison; J L Mohler; L A Lewis; W A Speir
Journal:  Lung       Date:  1979       Impact factor: 2.584

3.  Atopic asthmatic subjects but not atopic subjects without asthma have enhanced inflammatory response to ozone.

Authors:  Michelle L Hernandez; John C Lay; Bradford Harris; Charles R Esther; W June Brickey; Philip A Bromberg; David Diaz-Sanchez; Robert B Devlin; Steven R Kleeberger; Neil E Alexis; David B Peden
Journal:  J Allergy Clin Immunol       Date:  2010-09       Impact factor: 10.793

4.  Definitions of emphysema, chronic bronchitis, asthma, and airflow obstruction: 25 years on from the Ciba symposium.

Authors:  C M Fletcher; N B Pride
Journal:  Thorax       Date:  1984-02       Impact factor: 9.139

5.  Voluntary pulmonary function screening identifies high rates of undiagnosed asymptomatic chronic obstructive pulmonary disease.

Authors:  Shengyu Wang; Wei Gong; Yao Tian
Journal:  Chron Respir Dis       Date:  2016-02-11       Impact factor: 2.444

6.  A novel lung disease phenotype adjusted for mortality attrition for cystic fibrosis genetic modifier studies.

Authors:  Chelsea Taylor; Clayton W Commander; Joseph M Collaco; Lisa J Strug; Weili Li; Fred A Wright; Aaron D Webel; Rhonda G Pace; Jaclyn R Stonebraker; Kathleen Naughton; Ruslan Dorfman; Andrew Sandford; Scott M Blackman; Yves Berthiaume; Peter Paré; Mitchell L Drumm; Julian Zielenski; Peter Durie; Garry R Cutting; Michael R Knowles; Mary Corey
Journal:  Pediatr Pulmonol       Date:  2011-04-01

7.  Cardiopulmonary response to oxygen therapy in hypoxaemic chronic airflow obstruction.

Authors:  J M Hunt; J Copland; C F McDonald; C E Barter; P D Rochford; R J Pierce
Journal:  Thorax       Date:  1989-11       Impact factor: 9.139

8.  Ventilatory effects of long-term treatment with pindolol and metoprolol in hypertensive patients with chronic obstructive lung disease.

Authors:  J W Lammers; H T Folgering; C L van Herwaarden
Journal:  Br J Clin Pharmacol       Date:  1985-09       Impact factor: 4.335

9.  Effect of aerosol particle size on bronchodilatation with nebulised terbutaline in asthmatic subjects.

Authors:  M M Clay; D Pavia; S W Clarke
Journal:  Thorax       Date:  1986-05       Impact factor: 9.139

10.  Normal Routine Spirometry Can Mask COPD/Emphysema in Symptomatic Smokers.

Authors:  Arthur F Gelb; Alfred Yamamoto; Eric K Verbeken; James C Hogg; Donald P Tashkin; Diem N T Tran; Roxanna M Moridzadeh; Christine Fraser; Mark J Schein; Marc Decramer; Eric F Glassy; Jay A Nadel
Journal:  Chronic Obstr Pulm Dis       Date:  2021-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.